Chuck Ence - 16 May 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role: CA and CO
Signature: /s/ Chuck Ence
Issuer symbol: RLMD
Transactions as of: 16 May 2025
Net transactions value: +$103,330
Form type: 4
Filing time: 20 May 2025, 18:02:33 UTC
Previous filing: 29 May 2024
Next filing: 30 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ence Chuck	CA and CO	C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES,	/s/ Chuck Ence	20 May 2025	0001697779

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLMD	Common Stock	Purchase	$103,330	+228,961	+588%	$0.4513	267,931	16 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2	Purchase prices range from $0.401 to $0.4892 per share, inclusive.

Content

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.

Purchase prices range from $0.401 to $0.4892 per share, inclusive.